Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma

Journal of Vascular and Interventional Radiology

Volumn 22, Issue 12, 2011, Pages 1697-1705

  Lance, Craig ^a   McLennan, Gordon ^c   Obuchowski, Nancy ^b   Cheah, Grace ^c   Levitin, Abraham ^c   Sands, Mark ^c   Spain, James ^c   Srinivas, Shyam ^c   Shrikanthan, Sankaran ^c   Aucejo, Federico N ^c   Kim, Richard ^d   Menon, K V Narayanan ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Digestive Disease Institute   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

90Y; AFP; alpha fetoprotein; CI; confidence interval; Eastern Cooperative Oncology Group; ECOG; HCC; hepatocellular carcinoma; yttrium 90

Indexed keywords

BILIRUBIN; CISPLATIN; DOXORUBICIN; ETHIODIZED OIL; IODINATED CONTRAST MEDIUM; YTTRIUM 90;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEMOCHROMATOSIS; HEPATITIS; HEPATITIS B; HEPATITIS C; HOSPITAL READMISSION; HUMAN; HUMAN TISSUE; IATROGENIC DISEASE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RADIATION DOSE; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMORBIDITY; DRUG TOXICITY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; YTTRIUM RADIOISOTOPES;

EID: 81855194412     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.08.013     Document Type: Article

References (29)

1. J. Belghiti, B.I. Carr, P.D. Greig, R. Lencioni, and R.T. Poon Treatment before liver transplantation for HCC Ann Surg Oncol 15 2008 993 1000
2. R.J. Lewandowski, L.M. Kulik, and A. Riaz A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928
3. M. Tezuka, K. Hayashi, and K. Kubota Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma Dig Dis Sci 52 2007 783 788
4. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442 (Pubitemid 36152543)
5. J.M. Llovet, M.I. Real, X. Montana Barcelona Liver Cancer Group Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Lancet 359 2002 1734 1739 (Pubitemid 34607087)
6. C.M. Lo, H. Ngan, and W.K. Tso Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1164 1171 (Pubitemid 34454013)
7. Y.H. Huang, J.C. Wu, and S.C. Chen Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter Aliment Pharmacol Ther 23 2006 129 135
8. K. Takayasu, S. Arii, I. Ikai Liver Cancer Study Group of Japan Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients Gastroenterology 131 2006 461 469 (Pubitemid 44142456)
9. S. Miyayama, M. Yamashiro, and M. Okuda Chemoembolization for the treatment of large hepatocellular carcinoma J Vasc Interv Radiol 21 2010 1226 1234
10. B.I. Carr, V. Kondraqunta, S.C. Buch, and R.A. Branch Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study Cancer 116 2010 1305 1314
11. D.A. Kooby, V. Egnatashvili, and S. Srinivasan Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma J Vasc Interv Radiol 21 2010 224 230
12. R. Salem, R.J. Lewandowski, and L. Kulik Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma Gastroenterology 140 2011 497-507.e2
13. J. Bruix, M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236 (Pubitemid 43112690)
14. J. Bruix, M. Sherman, J.M. Llovet EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430 (Pubitemid 32844200)
15. J.M. Llovet, A.M. Di Bisceqlie, J. Bruix Panel of Experts in HCC-Design Clinical Trials Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
16. D.B. Brown, J.F. Cardella, and D. Sacks Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy J Vasc Interv Radiol 20 7 Suppl 2009 S219S226.e1e10
17. R. Salem, R.J. Lewandowski, V.L. Gates Technology Assessment Committee; Interventional Oncology Task Force of the Society of Interventional Radiology Research reporting standards for radioembolization of hepatic malignancies J Vasc Interv Radiol 22 2011 265 278
18. D.E. Ramsey, L.Y. Kernagis, M.C. Soulen, and J.F. Geschwind Chemoembolization of hepatocellular carcinoma J Vasc Interv Radiol 13 9 Pt 2 2002 S211 S221
19. D.M. Coldwell, K.R. Stokes, and W.F. Yakes Embolotherapy: agents, clinical applications, and techniques Radiographics 14 1994 623 643
20. A. Kennedy, S. Nag, and R. Salem Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23 (Pubitemid 46589861)
21. R.J. Lewandowski, K.T. Sato, and B. Atassi Radioembolization with 90Y microspheres: angiographic and technical considerations Cardiovasc Intervent Radiol 30 2007 571 592 (Pubitemid 350092259)
22. R. Salem, and K.G. Thurston Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies Part 1: technical and methodologic considerations J Vasc Interv Radiol 17 2006 1251 1278 (Pubitemid 44259009)
23. A.S. Kennedy, D. Coldwell, and C. Nutting Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience Int J Radiat Oncol Biol Phys 65 2006 412 425
24. L. Marelli, R. Stigliano, and C. Triantos Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies Cardiovasc Intervent Radiol 30 2007 6 25 (Pubitemid 44900485)
25. J. Lammer, K. Malagari, T. Vogl PRECISION V Investigators Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
26. R. Dhanasekaran, D.A. Kooby, C.A. Staley, J.S. Kauh, V. Khanna, and H.S. Kim Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocellular carcinoma (HCC) J Surg Oncol 101 2010 476 480
27. R. Salem, R.J. Lewandowski, and B. Atassi Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival J Vasc Interv Radiol 16 2005 1627 1639 (Pubitemid 44431160)
28. J.W. Mitchell, W.G. O'Connell, and P. Kisza Safety and feasibility of outpatient transcatheter hepatic arterial embolization for hepatocellular carcinoma J Vasc Interv Radiol 20 2009 203 208
29. D.H. Berger, C.H. Carrasco, D.C. Hohn, and S.A. Curley Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications J Surg Oncol 60 1995 116 121